 Kindred Biosciences Inc NASDAQ:KIN Cantor Fitzgerald raised their FY2020 EPS estimates for Kindred Biosciences in a report released on Wednesday, July 29th. Cantor Fitzgerald analyst B. Folkes now forecasts that the biopharmaceutical company will post earnings of 1.53 per share for the year, up from their previous forecast of 1.61. Cantor Fitzgerald currently has ... 